BRAIN Biotech AG (XETR:BNN) Share Price

Company Profile

Business description
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Contact
Darmstadter Strasse 34-36
ZwingenbergBW64673
DEU
T: +49 62519331
https://www.brain-biotech.com
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
30 September 2025
Employees
285

Recommended

We raise our risk and uncertainty rating to reflect the impact of the ruling.

Esther Holloway | 13 July 2025

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.

Sarah Hansen | 10 July 2025

Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.

Shaun Ler | 10 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,815.30	5.00	-0.06%
CAC 40	7,793.94	35.35	-0.45%
DAX 40	24,018.80	236.51	-0.98%
Dow JONES (US)	44,371.51	279.13	-0.63%
FTSE 100	8,975.78	34.66	0.39%
HKSE	24,203.32	63.75	0.26%
NASDAQ	20,585.53	45.14	-0.22%
Nikkei 225	39,459.62	110.06	-0.28%
NZX 50 Index	12,678.69	7.99	-0.06%
S&P 500	6,259.75	20.71	-0.33%
S&P/ASX 200	8,570.40	9.70	-0.11%
SSE Composite Index	3,519.65	9.47	0.27%